Cargando…
Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward
Triple negative breast cancer (TNBC) is a very aggressive subtype of breast cancer that lacks estrogen, progesterone, and HER2 receptor expression. TNBC is thought to be produced by Wnt, Notch, TGF-beta, and VEGF pathway activation, which leads to cell invasion and metastasis. To address this, the u...
Autores principales: | Alaouna, Mohammed, Penny, Clement, Hull, Rodney, Molefi, Thulo, Chauke-Malinga, Nkhensani, Khanyile, Richard, Makgoka, Malose, Bida, Meshack, Dlamini, Zodwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301029/ https://www.ncbi.nlm.nih.gov/pubmed/37375975 http://dx.doi.org/10.3390/plants12122350 |
Ejemplares similares
-
Viral Encoded miRNAs in Tumorigenesis: Theranostic Opportunities in Precision Oncology
por: Hull, Rodney, et al.
Publicado: (2022) -
Genomic Interplay between Neoneurogenesis and Neoangiogenesis in Carcinogenesis: Therapeutic Interventions
por: Dlamini, Zodwa, et al.
Publicado: (2023) -
Esophageal cancer genetics in South Africa
por: Alaouna, Mohammed, et al.
Publicado: (2019) -
Alternative Splicing Events and Their Clinical Significance in Colorectal Cancer: Targeted Therapeutic Opportunities
por: Manabile, Mosebo Armstrong, et al.
Publicado: (2023) -
MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets
por: Marima, Rahaba, et al.
Publicado: (2021)